Predictive biomarkers for checkpoint inhibitor-based immunotherapy
Gibney, Geoffrey T, Dr, Weiner, Louis M, Prof, Atkins, Michael B, Prof
Published in The lancet oncology (01.12.2016)
Published in The lancet oncology (01.12.2016)
Get full text
Journal Article
The current state of molecular testing in the treatment of patients with solid tumors, 2019
El‐Deiry, Wafik S., Goldberg, Richard M., Lenz, Heinz‐Josef, Shields, Anthony F., Gibney, Geoffrey T., Tan, Antoinette R., Brown, Jubilee, Eisenberg, Burton, Heath, Elisabeth I., Phuphanich, Surasak, Kim, Edward, Brenner, Andrew J., Marshall, John L.
Published in CA: a cancer journal for clinicians (01.07.2019)
Published in CA: a cancer journal for clinicians (01.07.2019)
Get full text
Journal Article
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
Patel, Sapna P., Othus, Megan, Chen, Yuanbin, Wright, G. Paul, Yost, Kathleen J., Hyngstrom, John R., Hu-Lieskovan, Siwen, Lao, Christopher D., Fecher, Leslie A., Truong, Thach-Giao, Eisenstein, Jennifer L., Chandra, Sunandana, Sosman, Jeffrey A., Kendra, Kari L., Wu, Richard C., Devoe, Craig E., Deutsch, Gary B., Hegde, Aparna, Khalil, Maya, Mangla, Ankit, Reese, Amy M., Ross, Merrick I., Poklepovic, Andrew S., Phan, Giao Q., Onitilo, Adedayo A., Yasar, Demet G., Powers, Benjamin C., Doolittle, Gary C., In, Gino K., Kokot, Niels, Gibney, Geoffrey T., Atkins, Michael B., Shaheen, Montaser, Warneke, James A., Ikeguchi, Alexandra, Najera, Jose E., Chmielowski, Bartosz, Crompton, Joseph G., Floyd, Justin D., Hsueh, Eddy, Margolin, Kim A., Chow, Warren A., Grossmann, Kenneth F., Dietrich, Eliana, Prieto, Victor G., Lowe, Michael C., Buchbinder, Elizabeth I., Kirkwood, John M., Korde, Larissa, Moon, James, Sharon, Elad, Sondak, Vernon K., Ribas, Antoni
Published in The New England journal of medicine (02.03.2023)
Published in The New England journal of medicine (02.03.2023)
Get full text
Journal Article
YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells
White, Shannon M., Avantaggiati, Maria Laura, Nemazanyy, Ivan, Di Poto, Cristina, Yang, Yang, Pende, Mario, Gibney, Geoffrey T., Ressom, Habtom W., Field, Jeffery, Atkins, Michael B., Yi, Chunling
Published in Developmental cell (06.05.2019)
Published in Developmental cell (06.05.2019)
Get full text
Journal Article
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
Weber, Jeffrey S, Carlino, Matteo S, Khattak, Adnan, Meniawy, Tarek, Ansstas, George, Taylor, Matthew H, Kim, Kevin B, McKean, Meredith, Long, Georgina V, Sullivan, Ryan J, Faries, Mark, Tran, Thuy T, Cowey, C Lance, Pecora, Andrew, Shaheen, Montaser, Segar, Jennifer, Medina, Theresa, Atkinson, Victoria, Gibney, Geoffrey T, Luke, Jason J, Thomas, Sajeve, Buchbinder, Elizabeth I, Healy, Jane A, Huang, Mo, Morrissey, Manju, Feldman, Igor, Sehgal, Vasudha, Robert-Tissot, Celine, Hou, Peijie, Zhu, Lili, Brown, Michelle, Aanur, Praveen, Meehan, Robert S, Zaks, Tal
Published in The Lancet (British edition) (17.02.2024)
Published in The Lancet (British edition) (17.02.2024)
Get full text
Journal Article
Safety, Efficacy, and Biomarkers of Nivolumab With Vaccine in Ipilimumab-Refractory or -Naive Melanoma
WEBER, Jeffrey S, RAGINI REINEY KUDCHADKAR, KROEGER, Jodi, EYSMANS, Cabell, SARNAIK, Amod A, ANN CHEN, Y, BIN YU, GALLENSTEIN, Donna, HORAK, Christine E, INZUNZA, H. David, XIUHUA ZHAO, MARTINEZ, Alberto J, WENSHI WANG, GIBNEY, Geoffrey
Published in Journal of clinical oncology (01.12.2013)
Published in Journal of clinical oncology (01.12.2013)
Get full text
Journal Article
Standard-Dose Pembrolizumab Plus Alternate-Dose Ipilimumab in Advanced Melanoma: KEYNOTE-029 Cohort 1C, a Phase 2 Randomized Study of Two Dosing Schedules
Long, Georgina V, Robert, Caroline, Butler, Marcus O, Couture, Felix, Carlino, Matteo S, O'Day, Steven, Atkinson, Victoria, Cebon, Jonathan S, Brown, Michael P, Dalle, Stéphane, Hill, Andrew G, Gibney, Geoffrey T, McCune, Steven, Menzies, Alexander M, Niu, Cuizhen, Ibrahim, Nageatte, Moreno, Blanca Homet, Diab, Adi
Published in Clinical cancer research (01.10.2021)
Published in Clinical cancer research (01.10.2021)
Get full text
Journal Article
Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma
Gibney, Geoffrey T, Kudchadkar, Ragini R, DeConti, Ronald C, Thebeau, Melissa S, Czupryn, Maria P, Tetteh, Leticia, Eysmans, Cabell, Richards, Allison, Schell, Michael J, Fisher, Kate J, Horak, Christine E, Inzunza, H David, Yu, Bin, Martinez, Alberto J, Younos, Ibrahim, Weber, Jeffrey S
Published in Clinical cancer research (15.02.2015)
Published in Clinical cancer research (15.02.2015)
Get full text
Journal Article
Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection
Shah, Neil J., Al-Shbool, Ghassan, Blackburn, Matthew, Cook, Michael, Belouali, Anas, Liu, Stephen V., Madhavan, Subha, He, Aiwu Ruth, Atkins, Michael B., Gibney, Geoffrey T., Kim, Chul
Published in Journal for immunotherapy of cancer (17.12.2019)
Published in Journal for immunotherapy of cancer (17.12.2019)
Get full text
Journal Article
A Multicenter Analysis of Immune Checkpoint Inhibitors as Adjuvant Therapy Following Treatment of Isolated Brain Metastasis
Randall Patrinely, J., Funck‐Brentano, Elisa, Nguyen, Khang, Rapisuwon, Suthee, Salem, Joe‐Elie, Gibney, Geoffrey T., Carlino, Matteo, Johnson, Douglas B.
Published in The oncologist (Dayton, Ohio) (01.03.2021)
Published in The oncologist (Dayton, Ohio) (01.03.2021)
Get full text
Journal Article
Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor
Johnson, Douglas B, Flaherty, Keith T, Weber, Jeffrey S, Infante, Jeffrey R, Kim, Kevin B, Kefford, Richard F, Hamid, Omid, Schuchter, Lynn, Cebon, Jonathan, Sharfman, William H, McWilliams, Robert R, Sznol, Mario, Lawrence, Donald P, Gibney, Geoffrey T, Burris, 3rd, Howard A, Falchook, Gerald S, Algazi, Alain, Lewis, Karl, Long, Georgina V, Patel, Kiran, Ibrahim, Nageatte, Sun, Peng, Little, Shonda, Cunningham, Elizabeth, Sosman, Jeffrey A, Daud, Adil, Gonzalez, Rene
Published in Journal of clinical oncology (20.11.2014)
Published in Journal of clinical oncology (20.11.2014)
Get full text
Journal Article
Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies
Sloot, Sarah, Chen, Yian A., Zhao, Xiuhua, Weber, Jamie L., Benedict, Jacob J., Mulé, James J., Smalley, Keiran S., Weber, Jeffrey S., Zager, Jonathan S., Forsyth, Peter A., Sondak, Vernon K., Gibney, Geoffrey T.
Published in Cancer (15.01.2018)
Published in Cancer (15.01.2018)
Get full text
Journal Article
The State of Melanoma: Emergent Challenges and Opportunities
Atkins, Michael B, Curiel-Lewandrowski, Clara, Fisher, David E, Swetter, Susan M, Tsao, Hensin, Aguirre-Ghiso, Julio A, Soengas, Maria S, Weeraratna, Ashani T, Flaherty, Keith T, Herlyn, Meenhard, Sosman, Jeffrey A, Tawbi, Hussein A, Pavlick, Anna C, Cassidy, Pamela B, Chandra, Sunandana, Chapman, Paul B, Daud, Adil, Eroglu, Zeynep, Ferris, Laura K, Fox, Bernard A, Gershenwald, Jeffrey E, Gibney, Geoffrey T, Grossman, Douglas, Hanks, Brent A, Hanniford, Douglas, Hernando, Eva, Jeter, Joanne M, Johnson, Douglas B, Khleif, Samir N, Kirkwood, John M, Leachman, Sancy A, Mays, Darren, Nelson, Kelly C, Sondak, Vernon K, Sullivan, Ryan J, Merlino, Glenn
Published in Clinical cancer research (15.05.2021)
Published in Clinical cancer research (15.05.2021)
Get full text
Journal Article
First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response
Yap, Timothy A, Gainor, Justin F, Callahan, Margaret K, Falchook, Gerald S, Pachynski, Russell K, LoRusso, Patricia, Kummar, Shivaani, Gibney, Geoffrey T, Burris, Howard A, Tykodi, Scott S, Rahma, Osama E, Seiwert, Tanguy Y, Papadopoulos, Kyriakos P, Blum Murphy, Mariela, Park, Haeseong, Hanson, Amanda, Hashambhoy-Ramsay, Yasmin, McGrath, Lara, Hooper, Ellen, Xiao, Xiaoying, Cohen, Heather, Fan, Martin, Felitsky, Daniel, Hart, Courtney, McComb, Rachel, Brown, Karen, Sepahi, Ali, Jimenez, Judith, Zhang, Weidong, Baeck, Johan, Laken, Haley, Murray, Richard, Trehu, Elizabeth, Harvey, Christopher J
Published in Clinical cancer research (01.09.2022)
Published in Clinical cancer research (01.09.2022)
Get full text
Journal Article
Clinical development of dabrafenib in BRAF mutant melanoma and other malignancies
Gibney, Geoffrey T, Zager, Jonathan S
Published in Expert opinion on drug metabolism & toxicology (01.07.2013)
Published in Expert opinion on drug metabolism & toxicology (01.07.2013)
Get more information
Journal Article
A paradigm shift in understanding vulvovaginal melanoma as a distinct tumor type compared with cutaneous melanoma
Wilhite, Annelise M., Wu, Sharon, Xiu, Joanne, Gibney, Geoffrey T., Phung, Thuy, In, Gino K., Herzog, Thomas J., Khabele, Dineo, Erickson, Britt K., Brown, Jubilee, Rocconi, Rodney P., Pierce, Jennifer Y., Scalici, Jennifer M., Jones, Nathaniel L.
Published in Gynecologic oncology (01.09.2024)
Published in Gynecologic oncology (01.09.2024)
Get full text
Journal Article
Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma
Gibney, Geoffrey T, Hamid, Omid, Lutzky, Jose, Olszanski, Anthony J, Mitchell, Tara C, Gajewski, Thomas F, Chmielowski, Bartosz, Hanks, Brent A, Zhao, Yufan, Newton, Robert C, Maleski, Janet, Leopold, Lance, Weber, Jeffrey S
Published in Journal for immunotherapy of cancer (20.03.2019)
Published in Journal for immunotherapy of cancer (20.03.2019)
Get full text
Journal Article